title: Prognostication of Survival in Patients With Advanced Cancer: Predicting the Unpredictable?
abstract: BACKGROUND
  Prognosis is a key driver of clinical decision-making. However, available prognostication tools have limited accuracy and variable levels of validation.
  
  
  METHODS
  Principles of survival prediction and literature on clinician prediction of survival, prognostic factors, and prognostic models were reviewed, with a focus on patients with advanced cancer and a survival rate of a few months or less.
  
  
  RESULTS
  The 4 principles of survival prediction are (a) prognostication is a process instead of an event, (b) prognostic factors may evolve over the course of the disease, (c) prognostic accuracy for a given prognostic factor/ tool varies by the definition of accuracy, the patient population, and the time frame of prediction, and (d) the exact timing of death cannot be predicted with certainty. Clinician prediction of survival is the most commonly used approach to formulate prognosis. However, clinicians often overestimate survival rates with the temporal question. Other clinician prediction of survival approaches, such as surprise and probabilistic questions, have higher rates of accuracy. Established prognostic factors in the advanced cancer setting include decreased performance status, delirium, dysphagia, cancer anorexia-cachexia, dyspnea, inflammation, and malnutrition. Novel prognostic factors, such as phase angle, may improve rates of accuracy. Many prognostic models are available, including the Palliative Prognostic Score, the Palliative Prognostic Index, and the Glasgow Prognostic Score.
  
  
  CONCLUSIONS
  Despite the uncertainty in survival prediction, existing prognostic tools can facilitate clinical decision-making by providing approximated time frames (months, weeks, or days). Future research should focus on clarifying and comparing the rates of accuracy for existing prognostic tools, identifying and validating novel prognostic factors, and linking prognostication to decision-making.
authors.affiliation: MD Anderson Cancer Center, Houston, TX. dhui@mdanderson.org.
authors.forename: David
authors.initials: D
authors.lastname: Hui
mesh_terms: D003657:Decision Making / Q000502:physiology; D006801:Humans; D009369:Neoplasms / Q000401:mortality* / Q000473:pathology*; D010166:Palliative Care / Q000379:methods; D011379:Prognosis